AZD5423 Multiple Ascending Dose Study

NCT01037504 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD5423
DRUG: Placebo

Sponsor

AstraZeneca